These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36597839)

  • 1. Heart failure related central sympathetic activation: debunking the 'holy grail'?
    Grassi G
    Eur J Heart Fail; 2023 Feb; 25(2):211-212. PubMed ID: 36597839
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.
    Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD
    J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
    Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
    Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion weighted imaging: have we found the 'Holy Grail' of diagnostic imaging or is it still a game of numbers?
    Herneth AM
    Eur J Radiol; 2003 Mar; 45(3):167-8. PubMed ID: 12595100
    [No Abstract]   [Full Text] [Related]  

  • 5. Sleep apnea in heart failure: implications of sympathetic nervous system activation for disease progression and treatment.
    Floras JS
    Curr Heart Fail Rep; 2005 Dec; 2(4):212-7. PubMed ID: 16332315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.
    Esler M; Kaye D
    Heart Fail Rev; 2000 Mar; 5(1):17-25. PubMed ID: 16228913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure.
    Andersen S; Andersen A; de Man FS; Nielsen-Kudsk JE
    Eur J Heart Fail; 2015 Apr; 17(4):358-66. PubMed ID: 25704592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation.
    Ciarka A; van de Borne P; Pathak A
    Expert Opin Investig Drugs; 2008 Sep; 17(9):1315-30. PubMed ID: 18694365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
    Zucker IH; Liu JL
    Heart Fail Rev; 2000 Mar; 5(1):27-43. PubMed ID: 16228914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure.
    Floras JS
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):72A-84A. PubMed ID: 8376699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic neuronal regulation of the heart in aging and heart failure.
    Kaye D; Esler M
    Cardiovasc Res; 2005 May; 66(2):256-64. PubMed ID: 15820194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic activation in congestive heart failure.
    Mancia G
    Eur Heart J; 1990 Apr; 11 Suppl A():3-11. PubMed ID: 2188836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic activation in congestive heart failure: an updated overview.
    Grassi G; Quarti-Trevano F; Esler MD
    Heart Fail Rev; 2021 Jan; 26(1):173-182. PubMed ID: 31832833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoreflexes--physiology and clinical implications.
    Kara T; Narkiewicz K; Somers VK
    Acta Physiol Scand; 2003 Mar; 177(3):377-84. PubMed ID: 12609009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation.
    Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD
    J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central and peripheral sympathetic activation in heart failure.
    Grassi G; Mancia G; Esler M
    Cardiovasc Res; 2022 Jun; 118(8):1857-1871. PubMed ID: 34240147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure.
    Notarius CF; Butler GC; Ando S; Pollard MJ; Senn BL; Floras JS
    Clin Sci (Lond); 1999 Jun; 96(6):557-65. PubMed ID: 10334961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.